| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Nikolaos G Baikoussis | Q57050356 |
| Ioanna Koniari | Q90718433 | ||
| P2093 | author name string | John Goudevenos | |
| Efstratios Apostolakis | |||
| Georgios Papadopoulos | |||
| Stavros N. Siminelakis | |||
| P2860 | cites work | High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II | Q22254095 |
| Progress in hemostasis and thrombosis | Q27712800 | ||
| Haematologica | Q5638209 | ||
| The Journal of Rheumatology | Q7743623 | ||
| The antiphospholipid syndrome and heart valve surgery | Q37033025 | ||
| Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment | Q37249527 | ||
| Antiphospholipid syndrome: intraoperative and postoperative anticoagulation in cardiac surgery | Q37298806 | ||
| Antiphospholipid antibodies: more than just a disease marker? | Q37920692 | ||
| Lupus anticoagulants | Q40267751 | ||
| Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis | Q40625241 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke | Q41089187 | ||
| Acute autoimmune cardiomyopathy in primary antiphospholipid antibody syndrome. | Q43987883 | ||
| Anticardiolipin antibodies are no marker for survived myocardial infarction | Q44087908 | ||
| Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome | Q44734227 | ||
| Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting | Q44753597 | ||
| Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery | Q44781826 | ||
| Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome | Q45049087 | ||
| Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins | Q45881942 | ||
| Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study | Q46533890 | ||
| Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery | Q47220344 | ||
| Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? | Q48021542 | ||
| Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome | Q48907545 | ||
| Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. | Q51618414 | ||
| Anaesthetic implications of the anti-cardiolipin antibody syndrome. | Q51665774 | ||
| The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. | Q52337223 | ||
| Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. | Q53354829 | ||
| [Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome] | Q54008203 | ||
| Antiphospholipid antibodies and venous thromboembolism | Q54157484 | ||
| Antiphospholipid antibodies in patients with previous myocardial infarction | Q67515191 | ||
| Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist | Q67925881 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events | Q69874910 | ||
| Coronary artery bypass graft failure--an autoimmune phenomenon? | Q69890603 | ||
| Radial artery occlusion in primary antiphospholipid syndrome after aortic valve replacement | Q70990876 | ||
| Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry | Q71112355 | ||
| Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation | Q71307820 | ||
| Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study | Q71691168 | ||
| Antiphospholipid antibodies lead to increased risk in cardiovascular surgery | Q71949874 | ||
| Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? | Q72383665 | ||
| Answers to the antiphospholipid-antibody syndrome? | Q72619115 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments | Q72702847 | ||
| Double valve replacement in a patient with anticardiolipin antibody syndrome | Q73025575 | ||
| Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty | Q73342706 | ||
| Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin | Q73396795 | ||
| Standardization of APTT reagents for heparin therapy monitoring: urgent or fading priority? | Q73496215 | ||
| Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients | Q73712556 | ||
| Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery | Q73778589 | ||
| Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant | Q73978345 | ||
| Guidelines on the investigation and management of the antiphospholipid syndrome | Q74121684 | ||
| Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators | Q74302912 | ||
| Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome | Q74537091 | ||
| Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon | Q77145794 | ||
| The antiphospholipid syndrome | Q77739053 | ||
| Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients | Q77943283 | ||
| A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice | Q79869726 | ||
| New anticoagulants | Q81064590 | ||
| Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study | Q81333645 | ||
| Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus | Q81402660 | ||
| Association of anticardiolipin antibodies levels with instent restenosis in patients with coronary artery disease | Q84119395 | ||
| Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2' | Q28179249 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome | Q33333387 | ||
| Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography | Q33334045 | ||
| Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery | Q33334149 | ||
| Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia | Q33357308 | ||
| Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome | Q33357759 | ||
| The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia | Q33361894 | ||
| Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery | Q33361897 | ||
| Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia | Q33363815 | ||
| Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia | Q33364888 | ||
| Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia | Q33366901 | ||
| Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome | Q33373931 | ||
| Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series | Q33375778 | ||
| Non-criteria manifestations of antiphospholipid syndrome | Q33388991 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Findings at necropsy in the heart of a patient with anticardiolipin syndrome | Q33434967 | ||
| Antiphospholipid antibodies: an elderly statesman Dons new garments | Q33446888 | ||
| Antiphospholipid antibodies and ischaemic heart disease | Q33494474 | ||
| Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass | Q33502495 | ||
| Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
| Anticardiolipin antibodies in ischaemic heart disease: marker or myth? | Q33612761 | ||
| Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome | Q33882709 | ||
| Antiphospholipid syndrome: insights from animal models | Q34015880 | ||
| Recent advances in antiphospholipid antibody-related valvulopathies | Q34021232 | ||
| Tissue factor pathway and the antiphospholipid syndrome | Q34021291 | ||
| The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients | Q34406031 | ||
| Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients | Q34435380 | ||
| Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome | Q35158386 | ||
| Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest | Q35561195 | ||
| Antiphospholipid syndrome: multiple mechanisms | Q35775322 | ||
| Inflammatory response and the endothelium. | Q35928642 | ||
| Coagulation assays for the lupus anticoagulant: review and critique of current methodology | Q35992527 | ||
| Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus | Q36896565 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| cardiovascular disease | Q389735 | ||
| antiphospholipid syndrome | Q582207 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 101 | |
| P577 | publication date | 2010-11-03 | |
| P1433 | published in | Journal of Cardiothoracic Surgery | Q2022384 |
| P1476 | title | Antiphospholipid syndrome; its implication in cardiovascular diseases: a review | |
| P478 | volume | 5 |
| Q52354916 | Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome. |
| Q40337946 | Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis |
| Q40153619 | Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q53552867 | Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls. |
| Q37140146 | Coronary artery fistula presenting as unstable angina pectoris in patients with antiphospholipid syndrome |
| Q37976385 | Coronary heart disease in young adults |
| Q39408792 | How the dissection laboratory facilitates integration of learning: presence of abdominal aortic aneurysm with a large intracardiac thrombus: a rare cadaver finding |
| Q26750752 | Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis |
| Q40958953 | Intravascular Images of Coronary Stenosis with Multiple Channels in a Patient with Antiphospholipid Syndrome: The Optical Coherence Tomography Findings |
| Q51425404 | Is aorto-arteritis a manifestation of primary antiphospholipid antibody syndrome? |
| Q46339090 | Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention |
| Q90261755 | Post-partum catastrophic antiphospholipid syndrome presenting with shock and digital ischaemia - A diagnostic and management challenge |
| Q33163886 | Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). |
| Q58998388 | Pulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review |
| Q33421577 | Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus. |
| Q26859847 | Rheumatic fever associated with antiphospholipid syndrome: systematic review |
| Q47636314 | Surgical Interventions for Organ and Limb Ischemia Associated With Primary and Secondary Antiphospholipid Antibody Syndrome With Arterial Involvement |
| Q36308509 | The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis |
| Q37959884 | The management of stroke in antiphospholipid syndrome |
| Q86630002 | [The catastrophic antiphospholipid antibody syndrome: case report and review of the literature] |
Search more.